Cargando…

(90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

BACKGROUND: The aim of this work was to confirm that post-selective internal radiation therapy (SIRT) (90)Y-PET/CT-based dosimetry correlates with lesion metabolic response and to determine its correlation with overall survival (OS) in liver-only metastases from colorectal cancer (mCRC) patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levillain, Hugo, Duran Derijckere, Ivan, Marin, Gwennaëlle, Guiot, Thomas, Vouche, Michaël, Reynaert, Nick, Hendlisz, Alain, Vanderlinden, Bruno, Flamen, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045565/ https://www.ncbi.nlm.nih.gov/pubmed/30006851 http://dx.doi.org/10.1186/s13550-018-0419-z

Ejemplares similares

Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2020)

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2021)

Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report
por: Herchuelz, Maxime, et al.
Publicado: (2020)

Quantitative (177)Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
por: Danieli, Rachele, et al.
Publicado: (2023)

Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy
por: Marin, Gwennaëlle, et al.
Publicado: (2017)

Prognostic value of a three-scale grading system based on combining molecular imaging with (68)Ga-DOTATATE and (18)F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias
por: Karfis, Ioannis, et al.
Publicado: (2020)

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
por: Buvat, Irène, et al.
Publicado: (2012)

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
por: Maisonobe, Jacques-Antoine, et al.
Publicado: (2012)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma
por: Vouche, Michael, et al.
Publicado: (2017)

Clinico‐metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases
por: Bohlok, Ali, et al.
Publicado: (2021)

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
por: Craciun, Ligia, et al.
Publicado: (2020)

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
por: Woff, Erwin, et al.
Publicado: (2016)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
por: Muylle, Kristoff, et al.
Publicado: (2015)

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
por: Chan, David L., et al.
Publicado: (2022)

Clinical impact of (99m)Tc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients
por: Bucalau, Ana-Maria, et al.
Publicado: (2023)

Effects of Respiratory Motion on Y-90 PET Dosimetry for SIRT
por: Walker, Matthew D., et al.
Publicado: (2022)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 ((90)Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with (90)Y microspheres
por: Knešaurek, Karin, et al.
Publicado: (2018)

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
por: Meyers, Nicolas, et al.
Publicado: (2020)

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
por: Camera, Silvia, et al.
Publicado: (2020)

SPECT/CT 90Y-Bremsstrahlung images for dosimetry during therapy
por: Fabbri, C, et al.
Publicado: (2008)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner
por: Linder, Pia M., et al.
Publicado: (2023)

Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging
por: Attarwala, Ali Asgar, et al.
Publicado: (2014)

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by (89)Zr-Trastuzumab and (18)F-FDG PET imaging
por: Wimana, Zéna, et al.
Publicado: (2017)

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report
por: Manta, Ringo, et al.
Publicado: (2022)

PET and PET/CT imaging of skeletal metastases
por: Cook, Gary J.R.
Publicado: (2010)

Understanding the Radiobiological Mechanisms Induced by (177)Lu-DOTATATE in Comparison to External Beam Radiation Therapy
por: Delbart, Wendy, et al.
Publicado: (2022)

SPECT/CT image‐based dosimetry for Yttrium‐90 radionuclide therapy: Application to treatment response
por: Potrebko, Peter S., et al.
Publicado: (2018)

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
por: Wagner, Antoine, et al.
Publicado: (2014)

Impact of (90)Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
por: Mikell, Justin K., et al.
Publicado: (2018)

Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates
por: Quinn, Brian, et al.
Publicado: (2016)

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study
por: Deleporte, Amelie, et al.
Publicado: (2014)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Dosimetry of patients submitted to cerebral PET/CT for the diagnosis of mild cognitive impairment
por: Santana, Priscila do Carmo, et al.
Publicado: (2014)

Comparison of the Biograph Vision and Biograph mCT for quantitative (90)Y PET/CT imaging for radioembolisation
por: Kunnen, Britt, et al.
Publicado: (2020)

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5or2uanjmo7dd79h46fla5icn